COVID-19 Update: Panel Discussion

In this COVID-19 update, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Learning Objectives

  • Discuss common questions about COVID-19 vaccination.
  • Review data about risk of COVID-19 in special populations.
  • Review the most recent data on masking.
  • Examine emerging COVID-19 treatments.

Additional Information

Partner: 
Pri-Med
Course summary
Available credit: 
  • 1.00 AANP Contact Hours
  • 0.33 AANP Pharmacology Contact Hours
  • 1.00 MOC
  • 1.00 AMA PRA Category 1 Credit
Course opens: 
01/12/2022
Course expires: 
01/12/2023
Rating: 
0

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence St. Joseph Health
Portland, OR

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine Director
UC Irvine Program in Medical Education for the Latino Community
Irvine, CA

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

Ty J. Gluckman, MD, FACC, FAHA: No relevant financial relationships disclosed.

Charles Vega, MD, FAAFP: No relevant financial relationships disclosed.

Pamela Kushner, MD, FAAFP (moderator): Stockholder with AstraZeneca and Lilly.

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

AMA PRA Category 1 Credits

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308. 

Designation Statement

This activity is approved for 1.00 contact hour of continuing education, which includes 0.33 hour of pharmacology.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

Instructions for Obtaining Credit

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 2 out of the 2 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.

Available Credit

  • 1.00 AANP Contact Hours
  • 0.33 AANP Pharmacology Contact Hours
  • 1.00 MOC
  • 1.00 AMA PRA Category 1 Credit
Please login or register to take this course.

This course is offered through Pri-Med. 

To take this course you will be redirected to Pri-Med's website. You must login or create an account with Pri-Med in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch